Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000875159 | SCV001017446 | likely benign | Adams-Oliver syndrome 5 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001593101 | SCV001817301 | likely benign | not provided | 2021-01-18 | criteria provided, single submitter | clinical testing | Nucleotide substitution has no predicted effect on splicing and is not conserved across species; Has not been previously published as pathogenic or benign to our knowledge |
Genome- |
RCV000875159 | SCV002554256 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271100 | SCV002554257 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004822259 | SCV005456592 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-08-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004530830 | SCV004712945 | likely benign | NOTCH1-related disorder | 2022-01-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |